glp-1 agonists in development Another milestone the evolution of GLP-1-based diabetes therapies Top GLP-1 Agonists Balance Weight

This technology enables extended pharmacological activity through the site-specific conjugation of a cysteine-albuminconjugated Exendin-4 analog (CA-Exendin-4) to the Fc fragment of human immunoglobulin G subclass 4 (IgG4), linked via a flexible peptide spacer (Fig

10.1016/j.molmet.2020.101102 95 NauckM

Major market players have adopted organic and inorganic strategies, including partnerships and investments

[DOI] [PubMed] [Google Scholar] 193.Hu Y., et al

This has led medical societies to issue guidance on managing these medications before elective procedures

Visceral fat leeches fatty acids called adipokines or chemokines, which cause systemic inflammation in the body